How to buy Insulet Corporation (PODD) stocks

Insulet Corporation is a medical devices business based in the US. Insulet Corporation shares (PODD) are listed on the NASDAQ and all prices are listed in US Dollars.

Its last market close was $255.44 – an increase of 1.44% over the previous week. Insulet Corporation employs 3,900 staff and has a trailing 12-month revenue of around $2.1 billion.

Our top picks for where to buy Insulet Corporation stock

Buy Insulet Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Insulet Corporation stock price (NASDAQ: PODD)

Use our graph to track the performance of PODD stocks over time.

Insulet Corporation stocks at a glance

• Key figures

Information last updated 2025-03-13.

Latest market close	$255.44
52-week range	$160.19 - $289.46
50-day moving average more info button	$272.25
200-day moving average more info button	$234.41
Wall St. target price	$314.06
PE ratio more info button	42.2573
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$5.79

Is it a good time to buy Insulet Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Insulet Corporation price performance over time

Historical closes compared with the close of $244.67 from 2025-03-13

1 week (2025-03-07)	-2.84%
1 month (2025-02-14)	-12.79%
3 months (2024-12-16)	-7.85%
6 months (2024-09-16)	4.61%

1 year (2024-03-15)	47.52%
2 years (2023-03-16)	-21.67%
3 years (2022-03-16)	2.53%
5 years (2020-03-16)	78.23%

Is Insulet Corporation stock undervalued or overvalued?

Valuing Insulet Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Insulet Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Insulet Corporation's P/E ratio

Insulet Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 42x. In other words, Insulet Corporation shares trade at around 42x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.

Insulet Corporation's PEG ratio

Insulet Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6.2827. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Insulet Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

Insulet Corporation's EBITDA

Insulet Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $389.7 million.

The EBITDA is a measure of a Insulet Corporation's overall financial performance and is widely used to measure a its profitability.

Insulet Corporation financials

Revenue TTM	$2.1 billion
Operating margin TTM	16.03%
Gross profit TTM	$1.4 billion
Return on assets TTM	6.8%
Return on equity TTM	43.03%
Profit margin	20.19%
Book value	$17.26
Market Capitalization more info button	$17.2 billion

TTM: trailing 12 months

Insulet Corporation stock dividends

We're not expecting Insulet Corporation to pay a dividend over the next 12 months.

Insulet Corporation stock price volatility

Over the last 12 months, Insulet Corporation's stocks have ranged in value from as little as $160.19 up to $289.46. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Insulet Corporation's is 1.287. This would suggest that Insulet Corporation's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Insulet Corporation overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts..

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Insulet Corporation is owned by insiders or institutions?
Currently 0.38% of Insulet Corporation stocks are held by insiders and 102.799% by institutions. How many people work for Insulet Corporation?
Latest data suggests 3,900 work at Insulet Corporation. When does the fiscal year end for Insulet Corporation?
Insulet Corporation's fiscal year ends in December. Where is Insulet Corporation based?
Insulet Corporation's address is: 100 Nagog Park, Acton, MA, United States, 01720 What is Insulet Corporation's ISIN number?
Insulet Corporation's international securities identification number is: US45784P1012 What is Insulet Corporation's CUSIP number?
Insulet Corporation's Committee on Uniform Securities Identification Procedures number is: 45784P101

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.